First Manhattan’s QuidelOrtho QDEL Stock Holding History

First Manhattan’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4	Closed	-$292	–	1548
2023 Q3	$292	Buy	+4	New	+$319	﹤0.01%	1404

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

First Manhattan's QDEL Position: Q4 2023 in Review

First Manhattan sold out of QuidelOrtho (QDEL) in Q4 2023, closing a stake of 4 shares — an estimated $292 sold.

First Manhattan first reported a position in QDEL in Q3 2023 and held it in 1 quarter. The position peaked at $292 in Q3 2023. 306 funds tracked by Wall St. Rank hold QDEL as of Q4 2023.

First Manhattan reported no remaining QuidelOrtho position as of Q4 2023 after selling out during the quarter.
First Manhattan sold 4 QuidelOrtho shares in Q4 2023, an estimated $292.
First Manhattan first reported a position in QuidelOrtho in Q3 2023 and held it in 1 quarter.
First Manhattan's QuidelOrtho position peaked at $292 in Q3 2023.
306 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2023.

Based on First Manhattan's 13F filing for Q4 2023, filed 13 Feb 2024.